Speaker Profile
PMWC PIONEER AWARD
Trailblazed the field of early cancer detection through a focus on tumor-shed DNA in bodily fluids; improved patient outcomes through development of the patient-derived xenograft (PDX) model
MD, Professor of Oncology, Johns Hopkins U.
Biography
David Sidransky is a renowned physician-scientist whose contributions have revolutionized the field of oncology precision medicine. He has developed non-invasive liquid biopsy methods for early cancer detection and many other translational molecular approaches. Dr. Sidransky's pioneering work has focused on the identification of genetic and epigenetic alterations in cancer. He was the first to identify altered DNA in stool, urine, sputum, saliva, and blood samples for cancer detection. His research has led to the development of several diagnostics and the use of PDX models for therapeutic drug development. Dr. Sidransky's exceptional achievements have earned him numerous awards and accolades including the AACR's Rosenthal award in 2004 and team science award in 2017. He has founded and served on the board of several biotechnology companies. He authored over 600 scientific articles and 30 patents and served on distinguished editorial boards. His dedication and accumulated work continue to inspire and guide researchers around the world.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Pioneer Honoree: Helmy Eltoukhy
Pioneer Honoree: AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy (PANEL)
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio
- Sylvia Katina Plevritis, Stanford - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, National Cancer Institute
- Sheila D. Walcoff, Goldbug Strategies LLC - Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - NCI Showcase
- Xiaohui Ni, Early Dx
- Daniel Kim, UCSC
